VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
PRVA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
PRVAPrivia Health Group, Inc.
$19.10$2.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPRVABalance Sheet

Privia Health Group, Inc. (PRVA) Balance Sheet

8Y historyFree accessUpdated daily

The balance sheet remains fortress-like with a D/E of 0.01 and $419.5M cash, though goodwill has grown 55% to $215.8M (14% of total assets), posing potential impairment risk.

Income StatementBalance SheetCash FlowRatios

PRVA Balance Sheet

Annual statement

PRVA Balance Sheet

Privia Health Group, Inc. (PRVA) balance sheet — 8-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18
Total Current Assets1.03T911M834.82M700.8M551.96M446.68M190.08M129.6M115.49M
Cash & Short-Term Investments419.52M479.69M491.15M389.51M347.99M320.58M84.63M46.89M39.11M
Cash Only419.52M479.69M491.15M389.51M347.99M320.58M84.63M46.89M39.11M
Short-Term Investments000000000
Accounts Receivable574.16B400.9M316.18M290.77M189.6M117.4M99.12M77.34M71.16M
Days Sales Outstanding22.27K68.9366.4664.0251.0144.3544.2835.939.5
Inventory000000000
Days Inventory Outstanding---------
Other Current Assets38.91B30.41M27.5M20.52M14.37M0000
Total Non-Current Assets463.31B458.38M300.96M299.1M240.85M239.7M138.88M140.61M134M
Property, Plant & Equipment8.31B9.3M6.07M8.94M11.47M14.14M4.81M5.62M698K
Fixed Asset Turnover1.13x228.31x286.06x185.49x118.23x68.35x169.73x139.87x942.13x
Goodwill215.79B209.84M141.62M138.75M126.94M127.94M118.66M118.66M118.66M
Intangible Assets218.65B215.92M109.81M107.63M57.39M59.74M5.98M6.62M7.26M
Long-Term Investments000000000
Other Non-Current Assets20.56B21.04M17.09M8.58M4.68M4.52M4.47M9.7M7.37M
Total Assets1.49T1.37B1.14B999.9M792.81M686.37M328.97M270.2M249.49M
Asset Turnover0.01x1.55x1.53x1.66x1.71x1.41x2.48x2.91x2.64x
Asset Growth %116935.26%20.57%13.59%26.12%15.51%108.64%21.75%8.31%-
Total Current Liabilities634.44B568.52M449.15M386.95M264.27M190.46M146.94M115.22M101.32M
Accounts Payable8.49M7.97M9.76M7.88M6.73M2.97M5.24M525K4.67M
Days Payables Outstanding23.291.522.281.922.011.22.60.272.83
Short-Term Debt2.07B0000875K875K3.38M7.13M
Deferred Revenue (Current)000000000
Other Current Liabilities632.37B503.07M370.61M332.05M214.6M148.2M112.98M86.86M4.39M
Current Ratio1.62x1.60x1.86x1.81x2.09x2.35x1.29x1.12x1.14x
Quick Ratio1.62x1.60x1.86x1.81x2.09x2.35x1.29x1.12x1.14x
Cash Conversion Cycle22.25K--------
Total Non-Current Liabilities16.06B9.91M3.19M5.56M9.49M45.73M38.38M47.53M62.12M
Long-Term Debt6.67B000031.69M32.78M39.73M59.87M
Capital Lease Obligations24.58M7.33M3.04M5.25M8.49M11.04M000
Deferred Tax Liabilities3.74B0000002.88M0
Other Non-Current Liabilities5.66B2.58M153K313K1M3M5.59M4.92M2.25M
Total Liabilities650.51B578.43M452.34M392.51M273.76M236.19M185.32M162.75M163.44M
Total Debt8.73B9.53M5.59M8.29M11.5M46.5M33.66M43.1M67M
Net Debt8.31B-470.15M-485.56M-381.22M-336.49M-274.08M-50.97M-3.79M27.89M
Debt / Equity0.01x0.01x0.01x0.01x0.02x0.10x0.23x0.40x0.78x
Debt / EBITDA153.38x0.22x0.23x0.30x--1.24x2.46x20.78x
Net Debt / EBITDA146.01x-10.65x-20.02x-14.02x---1.87x-0.22x8.65x
Interest Coverage------203.21x13.24x2.32x0.34x
Total Equity838.07B790.94M683.45M607.39M519.05M450.18M143.65M107.46M86.04M
Equity Growth %114194.05%15.73%12.52%17.02%15.3%213.38%33.68%24.89%-
Book Value per Share6357.366.145.444.874.694.171.361.020.84
Total Shareholders' Equity782.33B737.22M635.18M561.44M499.09M426.87M146.75M110.21M88.5M
Common Stock1.26B1.24M1.2M1.18M1.15M1.08M960K959K959K
Retained Earnings-144.2B-156.31M-179.23M-193.61M-216.69M-208.11M-19.88M-51.12M-59.37M
Treasury Stock000000000
Accumulated OCI000000000
Minority Interest55.74B53.73M48.26M45.95M19.95M23.31M-3.1M-2.76M-2.46M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStable
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Thin margins and EPS volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Strengthens on Cash Accumulation

Total assets grew from $1.0B to $1.5B over ten quarters, with equity rising to $782.3M, per reported figures, indicating a steadily strengthening balance sheet.

The balance sheet expansion is driven primarily by retained losses narrowing and cash accumulation, with cash holdings rising from $351.1M in 2024Q1 to $419.5M in 2026Q2. This suggests the company is generating sufficient cash to fund operations and growth without relying on external debt, reinforcing its financial flexibility.

Minimal Leverage Provides Strategic Optionality

Total debt remains negligible at $8.7M against $782.3M equity, yielding a D/E of 0.01, as per financial statements, indicating a fortress-like capital structure.

The near-zero leverage is a deliberate choice, as evidenced by the consistent D/E ratio across all quarters. This conservative approach provides a significant buffer against interest rate hikes and economic downturns, and positions the company to pursue strategic acquisitions or organic investments without the burden of debt service.

Asset-Light Model with Rising Goodwill

Goodwill increased from $139.5M to $215.8M over ten quarters, while PPE remains minimal at $8.3M, per reported data, highlighting an asset-light model with acquisition-driven intangibles.

The rise in goodwill suggests that the company has been making acquisitions to expand its provider network, which is consistent with its growth strategy. However, the increasing goodwill balance warrants monitoring for potential impairment if the acquired practices underperform. The minimal PPE underscores the service-oriented nature of the business, which relies on human capital and technology rather than physical assets.

Equity Growth Driven by Reduced Losses

Equity expanded from $576.8M to $782.3M, with retained earnings improving from -$190.6M to -$144.2M, per SEC filings, indicating a narrowing accumulated deficit.

The improvement in retained earnings reflects the company's path toward profitability, as net income has been positive in recent quarters. The absence of dividends or buybacks suggests that management is reinvesting all earnings back into the business to fuel growth, which is appropriate for a company in its expansion phase.

Strong Liquidity Position with Stable Current Ratio

Current ratio remains healthy at 1.62 in 2026Q2, with cash of $419.5M, as reported, providing ample buffer against short-term obligations.

The current ratio has been consistently above 1.6, indicating that current assets comfortably cover current liabilities. The substantial cash balance, which is roughly 28% of total assets, provides a cushion for working capital swings and potential investments. This liquidity is critical given the lumpy nature of value-based care revenue, as it allows the company to absorb timing differences without financial strain.

Goodwill Impairment Risk Lurks Beneath Growth

Goodwill has grown 55% to $215.8M, representing 14% of total assets, per financial statements, posing a potential impairment risk if acquisitions underperform.

The rapid increase in goodwill, driven by acquisitions, may indicate that the company is paying premiums for growth. If the acquired practices fail to generate expected synergies or if market conditions deteriorate, the company could face significant impairment charges, which would erode equity and net income. Investors should monitor the performance of these acquisitions closely, as the balance sheet's strength could be undermined by a write-down.

PRVA — Frequently Asked Questions

Quick answers to the most common questions about buying PRVA stock.

What are the total assets of Privia Health Group, Inc. (PRVA)?

As of 2025, Privia Health Group, Inc. (PRVA) had total assets of $1.37B including $911.0M in current assets.

How much debt does Privia Health Group, Inc. (PRVA) have?

Privia Health Group, Inc. (PRVA) carries total debt of $9.5M, offset by $479.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Privia Health Group, Inc.?

Privia Health Group, Inc. (PRVA) has total shareholders' equity (book value) of $737.2M ($6.14 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Privia Health Group, Inc.'s current ratio and liquidity?

Privia Health Group, Inc. (PRVA) reported a current ratio of 1.60x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.